Kilitch Drugs India has reported results for fourth quarter ended March 31, 2012
The company has posted a fall of 10.94% in its net profit at Rs 78.92 crore for the quarter ended March 31, 2012 as compared to Rs 88.62 crore for the same quarter in the previous year. Total income has decreased by 84.66% at Rs 16.39 crore for quarter under review as compared Rs 106.82 crore for the quarter ended March 31, 2011
For the full year ended March 31, 2012, on the consolidated basis, the company has posted a rise of 729.87% in its net profit at Rs 86.97 crore for the year ended March 31, 2012 as compared to Rs 10.48 crore for the same period in the previous year. However, total income has decreased by 25.63% at Rs 108.80 crore for year under review as compared to Rs 146.30 crore for the period ended March 31, 2011.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1823.25 |
Dr. Reddys Lab | 1182.15 |
Cipla | 1555.90 |
Lupin | 2093.30 |
Zydus Lifesciences | 889.60 |
View more.. |